- ￥2570 - 16740
- Sino Biological
- 北京
- 10698-H02H
- 2025年08月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
在-20℃ to -80℃
- 保质期：
12个月
- 英文名：
Recombinant Human CD80 / B7-1 Protein (ECD, Fc Tag)
- 库存：
99
- 供应商：
北京义翘神州科技股份有限公司
- 规格：
100 µg/1 mg
| 规格： | 100 µg | 产品价格： | ￥2570.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥16740.0 |
重组人 CD80 / B7-1 蛋白 (ECD, Fc标签)（产品说明）
蛋白名称：Human CD80 / B7-1 Protein (ECD, Fc Tag)
蛋白构建：A DNA sequence encoding the human CD80 (NP_005182.1) (Met1-Asn242) was expressed with the Fc region of human IgG1 at the C-terminus.
表达宿主：HEK293 Cells
蛋白纯度：> 95 % as determined by SDS-PAGE.
蛋白活性：0
蛋白内毒素：< 1.0 EU per μg protein as determined by the LAL method.
预测N端：Val 35
蛋白分子量：The recombinant human CD80 consists of 446 amino acids and predicts a molecular mass of 50.6 kDa. As a result of glycosylation, it migrates as an approximately 65.8 kDa band in SDS-PAGE under reducing conditions.
蛋白NP号：NP_005182.1
蛋白氨基酸序列：Met1-Asn242
蛋白标签：C-human IgG1-Fc
蛋白保存条件：Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
蛋白名称：Human CD80 / B7-1 Protein (ECD, Fc Tag)
蛋白构建：A DNA sequence encoding the human CD80 (NP_005182.1) (Met1-Asn242) was expressed with the Fc region of human IgG1 at the C-terminus.
表达宿主：HEK293 Cells
蛋白纯度：> 95 % as determined by SDS-PAGE.
蛋白活性：0
蛋白内毒素：< 1.0 EU per μg protein as determined by the LAL method.
预测N端：Val 35
蛋白分子量：The recombinant human CD80 consists of 446 amino acids and predicts a molecular mass of 50.6 kDa. As a result of glycosylation, it migrates as an approximately 65.8 kDa band in SDS-PAGE under reducing conditions.
蛋白NP号：NP_005182.1
蛋白氨基酸序列：Met1-Asn242
蛋白标签：C-human IgG1-Fc
蛋白保存条件：Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
1, Park, J; et al. Immune Checkpoint Inhibitor-Induced Reinvigoration of Tumor-Infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma. Clin. Cancer Res., Pubmed: 30659023
2, Xu, X; et al. CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis. The Journal of experimental medicine, Pubmed: 37042938
3, Liu, M; et al. Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy. Science translational medicine, Pubmed: 36857433
4, Xu, Y; et al. A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice. Cancer Immunol. Immunother., Pubmed: 31428800
2, Xu, X; et al. CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis. The Journal of experimental medicine, Pubmed: 37042938
3, Liu, M; et al. Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy. Science translational medicine, Pubmed: 36857433
4, Xu, Y; et al. A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice. Cancer Immunol. Immunother., Pubmed: 31428800
技术资料暂无技术资料 索取技术资料
文献支持
Recombinant Human CD80 / B7-1 Protein (ECD, Fc Tag) | 重组人 CD80 / B7-1 蛋白 (ECD, Fc标签)
￥2570 - 16740
